ARCHIVES

DeVita Resigns As No. 2 At Sloan-Kettering To “Pursue Clinical Research,” Hospital Says

This article is from The Cancer Letter archive.

Vol. 17 No. 22 | May 31, 1991

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Funding: Shalala Approves Agreement Over Disputed $14 Million

August 8, 1997

In Breif: Folkman selected For Karnofsky Lecture; Sporn to give ACS Lecture At ASCO

February 2, 1996

In Brief: Increasing Survival Through Adjuvant Therapy Seen As Adding To Cost Of Care

October 24, 1975

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012

NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit

April 29, 2005

In Brief: Three Centers Win Comprehensive Designation; Hiatt Named Deputy Director, NCI Cancer Control

October 31, 1997